Northern Trust’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Other funds holding TELO
PWM
Northern Trust's TELO Position: Q3 2026 in Review
Northern Trust increased its Telomir Pharmaceuticals (TELO) stake by 70% in Q3 2026, buying an estimated $50.9K and bringing the position to 104,894 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.
Northern Trust first reported a position in TELO in Q3 2024 and has held it in 9 quarters since. The position peaked at $625K in Q4 2024. 26 funds tracked by Wall St. Rank hold TELO as of Q3 2026.
- Northern Trust held 104,894 shares of Telomir Pharmaceuticals worth $126K as of Q3 2026.
- Northern Trust bought 43,362 Telomir Pharmaceuticals shares in Q3 2026, an estimated $50.9K.
- Telomir Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4044 holding.
- Northern Trust first reported a position in Telomir Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- Northern Trust's Telomir Pharmaceuticals position peaked at $625K in Q4 2024.
- 26 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.